tenapanor hydrochloride

FDA Drug Profile — IBSRELA

Drug Details

Generic Name
tenapanor hydrochloride
Brand Names
IBSRELA
Application Number
NDA211801
Sponsor
Patheon Pharmaceuticals Inc.
NDC Codes
2
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
TENAPANOR HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. IBSRELA is a sodium/hydrogen exchanger 3 (NHE3) inhibitor indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. ( 1 )